Department of Bioengineering at Stanford University, Stanford, CA, USA.
Department of Radiology at Stanford University, Stanford, CA, USA.
Mol Imaging Biol. 2023 Dec;25(6):1063-1072. doi: 10.1007/s11307-023-01850-5. Epub 2023 Sep 21.
Innate immune activation plays a critical role in the onset and progression of many diseases. While positron emission tomography (PET) imaging provides a non-invasive means to visualize and quantify such immune responses, most available tracers are not specific for innate immune cells. To address this need, we developed [F]OP-801 by radiolabeling a novel hydroxyl dendrimer that is selectively taken up by reactive macrophages/microglia and evaluated its ability to detect innate immune activation in mice following lipopolysaccharide (LPS) challenge.
OP-801 was radiolabeled in two steps: [F]fluorination of a tosyl precursor to yield [F]3-fluoropropylazide, followed by a copper-catalyzed click reaction. After purification and stability testing, [F]OP-801 (150-250 μCi) was intravenously injected into female C57BL/6 mice 24 h after intraperitoneal administration of LPS (10 mg/kg, n=14) or saline (n=6). Upon completing dynamic PET/CT imaging, mice were perfused, and radioactivity was measured in tissues of interest via gamma counting or autoradiography.
[F]OP-801 was produced with >95% radiochemical purity, 12-52 μCi/μg specific activity, and 4.3±1.5% decay-corrected yield. Ex vivo metabolite analysis of plasma samples (n=4) demonstrated high stability in mice (97±3% intact tracer >120 min post-injection). PET/CT images of mice following LPS challenge revealed higher signal in organs known to be inflamed in this context, including the liver, lung, and spleen. Gamma counting confirmed PET findings, showing significantly elevated signal in the same tissues compared to saline-injected mice: the liver (p=0.009), lung (p=0.030), and spleen (p=0.004). Brain PET/CT images (summed 50-60 min) revealed linearly increasing [F]OP-801 uptake in the whole brain that significantly correlated with murine sepsis score (r=0.85, p<0.0001). Specifically, tracer uptake was significantly higher in the brain stem, cortex, olfactory bulb, white matter, and ventricles of LPS-treated mice compared to saline-treated mice (p<0.05).
[F]OP-801 is a promising new PET tracer for sensitive and specific detection of activated macrophages and microglia that warrants further investigation.
先天免疫激活在许多疾病的发生和进展中起着关键作用。正电子发射断层扫描(PET)成像提供了一种非侵入性的方法来可视化和定量这种免疫反应,但大多数可用的示踪剂对先天免疫细胞不具有特异性。为了满足这一需求,我们通过放射性标记一种新型的羟基金刚烷,开发了[F]OP-801,该化合物被反应性巨噬细胞/小胶质细胞选择性摄取,并评估了其在脂多糖(LPS)挑战后检测小鼠先天免疫激活的能力。
OP-801 通过两步法进行放射性标记:对甲苯磺酰前体进行[F]氟化以得到[F]3-氟丙基叠氮化物,然后进行铜催化点击反应。经过纯化和稳定性测试后,将[F]OP-801(150-250 μCi)静脉注射到雌性 C57BL/6 小鼠中,在腹腔注射 LPS(10 mg/kg,n=14)或生理盐水(n=6)后 24 小时。在完成动态 PET/CT 成像后,通过灌注使小鼠完成成像,并通过γ计数或放射自显影法测量感兴趣组织中的放射性。
[F]OP-801 的放射化学纯度>95%,比活度为 12-52 μCi/μg,衰减校正产率为 4.3±1.5%。对 4 只小鼠的血浆样本进行的体外代谢分析表明,[F]OP-801 在小鼠体内具有很高的稳定性(>120 分钟时 97±3%的完整示踪剂)。LPS 挑战后小鼠的 PET/CT 图像显示,在肝脏、肺和脾脏等已知在此背景下发炎的器官中信号更高。γ计数证实了 PET 发现,与生理盐水注射的小鼠相比,相同组织中的信号显著升高:肝脏(p=0.009)、肺(p=0.030)和脾(p=0.004)。脑 PET/CT 图像(50-60 分钟总和)显示整个大脑中[F]OP-801 的摄取呈线性增加,与小鼠败血症评分显著相关(r=0.85,p<0.0001)。具体而言,与生理盐水处理的小鼠相比,LPS 处理的小鼠的脑干、皮质、嗅球、白质和脑室中的示踪剂摄取明显更高(p<0.05)。
[F]OP-801 是一种有前途的新型 PET 示踪剂,可用于敏感和特异性检测激活的巨噬细胞和小胶质细胞,值得进一步研究。